Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2022

01-12-2022 | Insulins | Study protocol

The effects of high-intensity functional training on cardiometabolic risk factors and exercise enjoyment in men and women with metabolic syndrome: study protocol for a randomized, 12-week, dose-response trial

Authors: L. E. Smith, G. P. Van Guilder, L. C. Dalleck, N. K. Harris

Published in: Trials | Issue 1/2022

Login to get access

Abstract

Background

Individuals with metabolic syndrome (MetS) are at a greater risk for developing atherosclerotic cardiovascular disease (ASCVD) than those without MetS, due to underlying endothelial dysfunction, dyslipidemia, and insulin resistance. Exercise is an effective primary and secondary prevention strategy for MetS; however, less than 25% of adults meet the minimum stated public recommendations. Barriers often identified are lack of enjoyment and lack of time. High-intensity functional training (HIFT), a time-efficient modality of exercise, has shown some potential to elicit positive affectivity and elicit increased fitness and improved glucose metabolism. However, the effects of HIFT on dyslipidemia and endothelial dysfunction have not been explored nor have the effects been explored in a population with MetS. Additionally, no studies have investigated the minimal dose of HIFT per week to see clinically meaningful changes in cardiometabolic health. The purpose of this study is to (1) determine the dose-response effect of HIFT on blood lipids, insulin resistance, and endothelial function and (2) determine the dose-response effect of HIFT on body composition, fitness, and perceived enjoyment and intention to continue the exercise.

Methods/design

In this randomized, dose-response trial, participants will undergo a 12-week HIFT intervention of either 1 day/week, 2 days/week, or 3 days/week of supervised, progressive exercise. Outcomes assessed at baseline and post-intervention will be multiple cardiometabolic markers, and fitness. Additionally, the participant’s affective response will be measured after the intervention.

Discussion

The findings of this research will provide evidence on the minimal dose of HIFT per week to see clinically meaningful improvements in the risk factors of MetS, as well as whether this modality is likely to mitigate the barriers to exercise. If an effective dose of HIFT per week is determined and if this modality is perceived positively, it may provide exercise specialists and health care providers a tool to prevent and treat MetS.

Trial registration

ClinicalTrials.gov NCT05001126. August 11, 2021.
Literature
1.
2.
3.
Laing SP, Swerdlow AJ, Slater SD, Burden AC, Morris A, Waugh NR, et al. Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia. 2003;46(6):760–5.CrossRefPubMed
4.
Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP. National cholesterol education program versus world health organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio heart study. Circulation. 2004;110(10):1251–7.CrossRefPubMed
5.
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735–52.CrossRefPubMed
6.
7.
Palmer MK, Toth PP. Trends in lipids, obesity, metabolic syndrome, and diabetes mellitus in the United States: an NHANES analysis (2003-2004 to 2013-2014). Obesity. 2019;27(2):309–14.CrossRefPubMed
8.
American College of Sports Medicine, Liguori G, Feito Y, Fountaine C, Roy B. ACSM’s guidelines for exercise testing and prescription. 11th ed. Philadelphia: Wolters Kluwer; 2021. p. 1.
9.
Dalleck LC, Van Guilder GP, Quinn EM, Bredle DL. Primary prevention of metabolic syndrome in the community using an evidence-based exercise program. Prev Med. 2013;57(4):392–5.CrossRefPubMed
10.
Dalleck L, Van Guilder G, Richardson T, Bredle D, Janot J. A community-based exercise intervention transitions metabolically abnormal obese adults to a metabolically healthy obese phenotype. Diabetes Metab Syndr Obes Targets Ther. 2014;7:369.CrossRef
11.
12.
Muscella A, Stefàno E, Marsigliante S. The effects of exercise training on lipid metabolism and coronary heart disease. Am J Physiol-Heart Circ Physiol. 2020;319(1):H76–88.CrossRefPubMed
13.
Mann S, Beedie C, Jimenez A. Differential effects of aerobic exercise, resistance training and combined exercise modalities on cholesterol and the lipid profile: review, synthesis and recommendations. Sports Med. 2014;44(2):211–21.CrossRefPubMed
14.
Lira FS, Carnevali LC, Zanchi NE, Santos RVT, Lavoie JM, Seelaender M. Exercise intensity modulation of hepatic lipid metabolism. J Nutr Metab. 2012;2012:1–8.CrossRef
15.
Tambalis K, Panagiotakos DB, Kavouras SA, Sidossis LS. Responses of blood lipids to aerobic, resistance, and combined aerobic with resistance exercise training: a systematic review of current evidence. Angiology. 2009;60(5):614–32.CrossRefPubMed
16.
Durstine J, Grandjean P, Cox C, Thompson P. Lipids, lipoproteins, and exercise. J Cardpulm Rehabil. 2002;22(6):385–98.CrossRef
17.
Sarzynski MA, Burton J, Rankinen T, Blair SN, Church TS, Després J-P, et al. The effects of exercise on the lipoprotein subclass profile: a meta-analysis of 10 interventions. Atherosclerosis. 2015;243(2):364–72.PubMedCentralPubMedCrossRef
18.
Costa RR, Buttelli ACK, Vieira AF, Coconcelli L, de Lima Magalhães R, Delevatti RS, et al. Effect of strength training on lipid and inflammatory outcomes: systematic review with meta-analysis and meta-regression. J Phys Act Health. 2019;16(6):477–91.CrossRefPubMed
19.
Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee I-M, et al. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc. 2011;43(7):1334–59.CrossRefPubMed
20.
Colberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ, Rubin RR, et al. Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement. Diabetes Care. 2010;33(12):e147–67.PubMedCentralPubMedCrossRef
21.
Carlson DJ, Dieberg G, Hess NC, Millar PJ, Smart NA. Isometric exercise training for blood pressure management: a systematic review and meta-analysis. Mayo Clin Proc. 2014;89(3):327–34.CrossRefPubMed
22.
23.
Grundy SM. Atherogenic dyslipidemia associated with metabolic syndrome and insulin resistance. Clin Cornerstone. 2006;8:S21–7.CrossRefPubMed
24.
Malave H, Castro M, Burkle J, Voros S, Dayspring T, Honigberg R, et al. Evaluation of low-density lipoprotein particle number distribution in patients with type 2 diabetes mellitus with low-density lipoprotein cholesterol <50 mg/dl and non-high-density lipoprotein cholesterol <80 mg/dl. Am J Cardiol. 2012;110(5):662–5.CrossRefPubMed
25.
Galeano N, Al-Haideri M, Keyserman F, Rumsey S, Deckelbaum R. Small dense low density lipoprotein has increased affinity for LDL receptor-independent cell surface binding sites: a potential mechanism for increased atherogenicity. J Lipid Res. 1998;39(6):1263–73.CrossRefPubMed
26.
de Winther MPJ, van Dijk KW, Havekes LM, Hofker MH. Macrophage scavenger receptor class A: a multifunctional receptor in atherosclerosis. Arterioscler Thromb Vasc Biol. 2000;20(2):290–7.CrossRefPubMed
27.
Toth P. Insulin resistance, small LDL particles, and risk for atherosclerotic disease. Curr Vasc Pharmacol. 2014;12(4):653–7.CrossRefPubMed
28.
Sniderman AD, Islam S, Yusuf S, McQueen MJ. Discordance analysis of apolipoprotein B and non-high density lipoprotein cholesterol as markers of cardiovascular risk in the INTERHEART study. Atherosclerosis. 2012;225(2):444–9.CrossRefPubMed
29.
Pencina MJ, D’Agostino RB, Zdrojewski T, Williams K, Thanassoulis G, Furberg CD, et al. Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-C. Eur J Prev Cardiol. 2015;22(10):1321–7.CrossRefPubMed
30.
Wilkins JT, Li RC, Sniderman A, Chan C, Lloyd-Jones DM. Discordance between apolipoprotein B and LDL-cholesterol in young adults predicts coronary artery calcification. J Am Coll Cardiol. 2016;67(2):193–201.PubMedCentralPubMedCrossRef
31.
Lawler PR, Akinkuolie AO, Ridker PM, Sniderman AD, Buring JE, Glynn RJ, et al. Discordance between circulating atherogenic cholesterol mass and lipoprotein particle concentration in relation to future coronary events in women. Clin Chem. 2017;63(4):870–9.PubMedCentralPubMedCrossRef
32.
Cromwell WC, Otvos JD, Keyes MJ, Pencina MJ, Sullivan L, Vasan RS, et al. LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study—implications for LDL management. J Clin Lipidol. 2007;1(6):583–92.PubMedCentralPubMedCrossRef
33.
Otvos JD, Mora S, Shalaurova I, Greenland P, Mackey RH, Goff DC. Clinical implications of discordance between low-density lipoprotein cholesterol and particle number. J Clin Lipidol. 2011;5(2):105–13.PubMedCentralPubMedCrossRef
34.
Mora S, Otvos JD, Rifai N, Rosenson RS, Buring JE, Ridker PM. Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation. 2009;119(7):931–9.PubMedCentralPubMedCrossRef
35.
Welsh C, Celis-Morales CA, Brown R, Mackay DF, Lewsey J, Mark PB, et al. Comparison of conventional lipoprotein tests and apolipoproteins in the prediction of cardiovascular disease: data from UK Biobank. Circulation. 2019;140(7):542–52.PubMedCentralPubMedCrossRef
36.
Kraus WE, Torgan CE, Duscha BD, Norris J, Brown SA, Cobb FR, et al. Studies of a targeted risk reduction intervention through defined exercise (STRRIDE). Med Sci Sports Exerc. 2001;33(10):1774–84.PubMedCrossRef
37.
Bateman LA, Slentz CA, Willis LH, Shields AT, Piner LW, Bales CW, et al. Comparison of aerobic versus resistance exercise training effects on metabolic syndrome (from the Studies of a Targeted Risk Reduction Intervention Through Defined Exercise - STRRIDE-AT/RT). Am J Cardiol. 2011;108(6):838–44.PubMedCentralPubMedCrossRef
38.
Thijssen DHJ, Black MA, Pyke KE, Padilla J, Atkinson G, Harris RA, et al. Assessment of flow-mediated dilation in humans: a methodological and physiological guideline. Am J Physiol-Heart Circ Physiol. 2011;300(1):H2–12.PubMedCrossRef
39.
Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation. 2000;101(9):948–54.CrossRefPubMed
40.
Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet. 1991;338(8782–8783):1546–50.PubMedCrossRef
41.
Li J, Zhao S-P, Li X-P, Zhuo Q-C, Gao M, Lu S-K. Non-invasive detection of endothelial dysfunction in patients with essential hypertension. Int J Cardiol. 1997;61(2):165–9.PubMedCrossRef
42.
Van Guilder GP, Hoetzer GL, Greiner JJ, Stauffer BL, DeSouza CA. Metabolic syndrome and endothelial fibrinolytic capacity in obese adults. Am J Physiol-Regul Integr Comp Physiol. 2008;294(1):R39–44.PubMedCrossRef
43.
Benjamin EJ, Larson MG, Keyes MJ, Mitchell GF, Vasan RS, Keaney JF, et al. Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study. Circulation. 2004;109(5):613–9.PubMedCrossRef
44.
Ashor AW, Lara J, Siervo M, Celis-Morales C, Oggioni C, Jakovljevic DG, et al. Exercise modalities and endothelial function: a systematic review and dose–response meta-analysis of randomized controlled trials. Sports Med. 2015;45(2):279–96.PubMedCrossRef
45.
Green DJ, Walsh JH, Maiorana A, Best MJ, Taylor RR, O’Driscoll JG. Exercise-induced improvement in endothelial dysfunction is not mediated by changes in CV risk factors: pooled analysis of diverse patient populations. Am J Physiol-Heart Circ Physiol. 2003;285(6):H2679–87.PubMedCrossRef
46.
Dawson EA, Green DJ, Timothy Cable N, Thijssen DHJ. Effects of acute exercise on flow-mediated dilatation in healthy humans. J Appl Physiol. 2013;115(11):1589–98.PubMedCrossRef
47.
Early KS, Stewart A, Johannsen N, Lavie CJ, Thomas JR, Welsch M. The effects of exercise training on brachial artery flow-mediated dilation: a meta-analysis. J Cardiopulm Rehabil Prev. 2017;37(2):77–89.CrossRefPubMed
48.
Mestek ML, Westby CM, Van Guilder GP, Greiner JJ, Stauffer BL, DeSouza CA. Regular aerobic exercise, without weight loss, improves endothelium-dependent vasodilation in overweight and obese adults. Obes Silver Spring Md. 2010;18(8):1667–9.CrossRef
49.
Miyachi M. Effects of resistance training on arterial stiffness: a meta-analysis. Br J Sports Med. 2013;47(6):393–6.PubMedCrossRef
50.
Lee J-H, Lee R, Hwang M-H, Hamilton MT, Park Y. The effects of exercise on vascular endothelial function in type 2 diabetes: a systematic review and meta-analysis. Diabetol Metab Syndr. 2018;10:15.PubMedCentralPubMedCrossRef
51.
Whitfield GP, Hyde ET, Carlson SA. Participation in leisure-time aerobic physical activity among adults, National Health Interview Survey, 1998–2018. J Phys Act Health. 2021;18(S1):S25–36.PubMedCrossRef
52.
Costello E, Kafchinski M, Vrazel J, Sullivan P. Motivators, barriers, and beliefs regarding physical activity in an older adult population. J Geriatr Phys Ther. 2001;34(3):138–47.CrossRef
53.
Greaney ML, Less FD, White AA, Dayton SF, Riebe D, Blissmer B, et al. College students’ barriers and enablers for healthful weight management: a qualitative study. J Nutr Educ Behav. 2009;41(4):281–6.PubMedCrossRef
54.
Korkiakangas EE, Alahuhta MA, Laitinen JH. Barriers to regular exercise among adults at high risk or diagnosed with type 2 diabetes: a systematic review. Health Promot Int. 2009;24(4):416–27.PubMedCrossRef
55.
Heinrich KM, Patel PM, O’Neal JL, Heinrich BS. High-intensity compared to moderate-intensity training for exercise initiation, enjoyment, adherence, and intentions: an intervention study. BMC Public Health. 2014;14:789.PubMedCentralPubMedCrossRef
56.
Thompson WR. Worldwide survey of fitness trends for 2020. ACSMs Health Fit J. 2019;23(6):10–8.CrossRef
57.
Feito Y, Heinrich KM, Butcher SJ, Poston WSC. High-intensity functional training (HIFT): definition and research implications for improved fitness. Sports. 2018;6(3):76.PubMedCentralCrossRef
58.
Nieuwoudt S, Fealy CE, Foucher JA, Scelsi AR, Malin SK, Pagadala M, et al. Functional high-intensity training improves pancreatic β-cell function in adults with type 2 diabetes. Am J Physiol-Endocrinol Metab. 2017;313(3):E314–20.PubMedCentralPubMedCrossRef
59.
Fealy CE, Nieuwoudt S, Foucher JA, Scelsi AR, Malin SK, Pagadala M, et al. Functional high-intensity exercise training ameliorates insulin resistance and cardiometabolic risk factors in type 2 diabetes. Exp Physiol. 2018;103(7):985–94.PubMedCentralPubMedCrossRef
60.
Posnakidis G, Aphamis G, Giannaki CD, Mougios V, Aristotelous P, Samoutis G, et al. High-intensity functional training improves cardiorespiratory fitness and neuromuscular performance without inflammation or muscle damage. J Strength Cond Res. 2020; Available from: https://​doi.​org/​10.​1519/​JSC.​0000000000003516​.
61.
Chukhlantseva N, Cherednychenko I, Kemkina V. The influence of high-intensity functional training versus resistance training on the main physical fitness indicators in women aged 25-35 years. Bibl Akad Wych Fiz W Poznaniu. 2020;27(3):157–65.
62.
Cosgrove SJ, Crawford DA, Heinrich KM. Multiple fitness improvements found after 6-months of high intensity functional training. Sports. 2019;7(9):203.PubMedCentralCrossRef
63.
Willis EA, Szabo-Reed AN, Ptomey LT, Honas JJ, Steger FL, Washburn RA, et al. Energy expenditure and intensity of group-based high-intensity functional training: a brief report. J Phys Act Health. 2019;16(6):470–6.PubMedCentralPubMedCrossRef
64.
Gibala MJ, Little JP, MacDonald MJ, Hawley JA. Physiological adaptations to low-volume, high-intensity interval training in health and disease. J Physiol. 2012;590(5):1077–84.PubMedCentralPubMedCrossRef
65.
Stavrinou PS, Bogdanis GC, Giannaki CD, Terzis G, Hadjicharalambous M. High-intensity interval training frequency: cardiometabolic effects and quality of life. Int J Sports Med. 2018;39(3):210–7.CrossRefPubMed
66.
Grgic J, Schoenfeld BJ, Davies TB, Lazinica B, Krieger JW, Pedisic Z. Effect of resistance training frequency on gains in muscular strength: a systematic review and meta-analysis. Sports Med. 2018;48(5):1207–20.CrossRefPubMed
67.
Schoenfeld BJ, Grgic J, Krieger J. How many times per week should a muscle be trained to maximize muscle hypertrophy? A systematic review and meta-analysis of studies examining the effects of resistance training frequency. J Sports Sci. 2019;37(11):1286–95.CrossRefPubMed
68.
Bakker EA, Lee D, Sui X, Artero EG, Ruiz JR, Eijsvogels TMH, et al. Association of resistance exercise, independent of and combined with aerobic exercise, with the incidence of metabolic syndrome. Mayo Clin Proc. 2017;92(8):1214–22.CrossRefPubMed
69.
Van Guilder GP, Kjellsen A. Adding a new technique to assess visceral obesity to your repertoire. ACSMs Health Fit J. 2020;24(1):19–25.CrossRef
70.
Block G, Woods M, Potosky A, Clifford C. Validation of a self-administered diet history questionnaire using multiple diet records. J Clin Epidemiol. 1990;43(12):1327–35.CrossRefPubMed
71.
Block G, Jensen CD, Block TJ, Norris J, Dalvi TB, Fung EB. The Work and Home Activities Questionnaire: energy expenditure estimates and association with percent body fat. J Phys Act Health. 2009;6(s1):S61–9.PubMedCentralPubMedCrossRef
72.
Huffman KM, Slentz CA, Kraus WE. Control arms in exercise training studies: transitioning from an era of intervention efficacy to one of comparative clinical effectiveness research. J Appl Physiol. 2011;111(3):946–8.PubMedCentralPubMedCrossRef
73.
Patel MJ, Slentz CA, Kraus WE. Metabolic deterioration of the sedentary control group in clinical trials. J Appl Physiol. 2011;111(4):1211–7.CrossRefPubMed
74.
Stenger L. What is functional/neuromotor fitness? ACSMs Health Fit J. 2018;22(6):35–43.CrossRef
75.
National Strength & Conditioning Association (U.S.), editor. Exercise technique manual for resistance training. 3rd edition. Champaign, IL: Human Kinetics; 2016. 207.
76.
Borg G. Borg’s range model and scales. Int J Sport Psychol. 2001;32(2):110–26.
77.
Foster C. Monitoring training in athletes with reference to overtraining syndrome. Med Sci Sports Exerc. 1998;30(7):1164–8.CrossRefPubMed
78.
Crawford D, Drake N, Carper M, DeBlauw J, Heinrich K. Validity, reliability, and application of the session-RPE method for quantifying training loads during high intensity functional training. Sports. 2018;6(3):84.PubMedCentralCrossRef
79.
Tibana R, De Sousa N, Cunha G, Prestes J, Fett C, Gabbett T, et al. Validity of session rating perceived exertion method for quantifying internal training load during high-intensity functional training. Sports. 2018;6(3):68.PubMedCentralCrossRef
80.
Turner A. The science and practice of periodization: a brief review. Strength Cond J. 2011;33(1):34–46.CrossRef
81.
Murach KA, Bagley JR. Less is more: the physiological basis for tapering in endurance, strength, and power athletes. Sports. 2015;3(3):209–18.CrossRef
82.
Spink KS, Wilson KS, Priebe CS. Groupness and adherence in structured exercise settings. Group Dyn Theory Res Pract. 2010;14(2):163–73.CrossRef
83.
Sarafidis PA, Lasaridis AN, Nilsson PM, Pikilidou MI, Stafilas PC, Kanaki A, et al. Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley’s indices in patients with hypertension and type II diabetes. J Hum Hypertens. 2007;21(9):709–16.CrossRefPubMed
84.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.CrossRefPubMed
85.
Ortega FB, Ruiz JR, España-Romero V, Vicente-Rodriguez G, Martínez-Gómez D, Manios Y, et al. The International Fitness Scale (IFIS): usefulness of self-reported fitness in youth. Int J Epidemiol. 2011;40(3):701–11.CrossRefPubMed
86.
Merellano-Navarro E, Collado-Mateo D, García-Rubio J, Gusi N, Olivares PR. Validity of the International Fitness Scale “IFIS” in older adults. Exp Gerontol. 2017;95:77–81.CrossRefPubMed
87.
Balke J, Ware R. An experimental study of “physical fitness” of Air Force personnel. US Armed Forces Med J. 1959;10(6):675–88.
88.
Astorino T, White A, Dalleck L. Supramaximal testing to confirm attainment of VO2max in sedentary men and women. Int J Sports Med. 2009;30(04):279–84.CrossRefPubMed
89.
Nolan P, Beaven M, Dalleck L. Comparison of intensities and rest periods for VO2max verification testing procedures. Int J Sports Med. 2014;35(12):1024–9.CrossRefPubMed
90.
Weatherwax R, Richardson T, Beltz N, Nolan P, Dalleck L. Verification testing to confirm VO2max in altitude-residing, endurance-trained runners. Int J Sports Med. 2016;37(07):525–30.CrossRefPubMed
91.
Kendzierski D, DeCarlo K. Physical activity enjoyment scale: two validation studies. J Sport Exerc Psychol. 1991;13:50–64.CrossRef
92.
Kwan BM, Bryan A. In-task and post-task affective response to exercise: translating exercise intentions into behaviour. Br J Health Psychol. 2010;15(1):115–31.CrossRefPubMed
93.
Heinrich KM, Crawford DA, Johns BR, Frye J, Gilmore KEO. Affective responses during high-intensity functional training compared to high-intensity interval training and moderate continuous training. Sport Exerc Perform Psychol. 2020;9(1):115–27.
94.
Sabaka P, Kruzliak P, Balaz D, Komornikova A, Celovska D, Cammarota G, et al. Effect of short term aerobic exercise on fasting and postprandial lipoprotein subfractions in healthy sedentary men. Lipids Health Dis. 2015;14(1):151.PubMedCentralPubMedCrossRef
95.
Grandjean PW, Crouse SF, Rohack JJ. Influence of cholesterol status on blood lipid and lipoprotein enzyme responses to aerobic exercise. J Appl Physiol. 2000;89(2):472–80.CrossRefPubMed
96.
Crouse SF, O’Brien BC, Grandjean PW, Lowe RC, Rohack JJ, Green JS. Effects of training and a single session of exercise on lipids and apolipoproteins in hypercholesterolemic men. J Appl Physiol. 1997;83(6):2019–28.CrossRefPubMed
97.
Paoli A, Pacelli QF, Moro T, Marcolin G, Neri M, Battaglia G, et al. Effects of high-intensity circuit training, low-intensity circuit training and endurance training on blood pressure and lipoproteins in middle-aged overweight men. Lipids Health Dis. 2013;12(1):131.PubMedCentralPubMedCrossRef
98.
Walldius G, Jungner I. Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy. J Intern Med. 2004;255(2):188–205.CrossRefPubMed
99.
Batrakoulis A, Jamurtas AZ, Georgakouli K, Draganidis D, Deli CK, Papanikolaou K, et al. High intensity, circuit-type integrated neuromuscular training alters energy balance and reduces body mass and fat in obese women: a 10-month training-detraining randomized controlled trial. PLoS ONE. 2018;13(8):e0202390.PubMedCentralPubMedCrossRef
100.
Batrakoulis A, Fatouros IG, Chatzinikolaou A, Draganidis D, Georgakouli K, Papanikolaou K, et al. Dose-response effects of high-intensity interval neuromuscular exercise training on weight loss, performance, health and quality of life in inactive obese adults: study rationale, design and methods of the DoIT trial. Contemp Clin Trials Commun. 2019;15:100386.PubMedCentralPubMedCrossRef
101.
102.
Alcaraz PE, Sánchez-Lorente J, Blazevich AJ. Physical performance and cardiovascular responses to an acute bout of heavy resistance circuit training versus traditional strength training. J Strength Cond Res. 2008;22(3):667–71.CrossRefPubMed
103.
Gibala MJ, Little JP. Physiological basis of brief vigorous exercise to improve health. J Physiol. 2020;598(1):61–9.CrossRefPubMed
104.
105.
Burgomaster KA, Howarth KR, Phillips SM, Rakobowchuk M, MacDonald MJ, McGee SL, et al. Similar metabolic adaptations during exercise after low volume sprint interval and traditional endurance training in humans. J Physiol. 2008;586(1):151–60.CrossRefPubMed
106.
Rakobowchuk M, Tanguay S, Burgomaster KA, Howarth KR, Gibala MJ, MacDonald MJ. Sprint interval and traditional endurance training induce similar improvements in peripheral arterial stiffness and flow-mediated dilation in healthy humans. Am J Physiol-Regul Integr Comp Physiol. 2008;295(1):R236–42.PubMedCentralPubMedCrossRef
107.
108.
Morton RW, Colenso-Semple L, Phillips SM. Training for strength and hypertrophy: an evidence-based approach. Curr Opin Physiol. 2019;10:90–5.CrossRef
109.
Logan GRM, Harris N, Duncan S, Plank LD, Merien F, Schofield G. Low-active male adolescents: a dose response to high-intensity interval training. Med Sci Sports Exerc. 2016;48(3):481–90.CrossRefPubMed
110.
Mikines KJ, Sonne B, Farrell PA, Tronier B, Galbo H. Effect of physical exercise on sensitivity and responsiveness to insulin in humans. Am J Physiol-Endocrinol Metab. 1988;254(3):E248–59.CrossRef
111.
Weise SD, Grandjean PW, Rohack JJ, Womack JW, Crouse SF. Acute changes in blood lipids and enzymes in postmenopausal women after exercise. J Appl Physiol. 2005;99(2):609–15.CrossRefPubMed
112.
Kesaniemi Y, Danforth E, Jensen M, Kopelman P, Lefèbvre P, Reeder B. Dose-response issues concerning physical activity and health: an evidence-based symposium. Med Sci Sports Exerc. 2001;33:S351–8.CrossRefPubMed
113.
Lira FS, Zanchi NE, Lima-Silva AE, Pires FO, Bertuzzi RC, Santos RV, et al. Acute high-intensity exercise with low energy expenditure reduced LDL-C and total cholesterol in men. Eur J Appl Physiol. 2009;107(2):203–10.CrossRefPubMed
114.
Ferguson MA, Alderson NL, Trost SG, Essig DA, Burke JR, Durstine JL. Effects of four different single exercise sessions on lipids, lipoproteins, and lipoprotein lipase. J Appl Physiol. 1998;85(3):1169–74.CrossRefPubMed
115.
Magkos F, Tsekouras YE, Prentzas KI, Basioukas KN, Matsama SG, Yanni AE, et al. Acute exercise-induced changes in basal VLDL-triglyceride kinetics leading to hypotriglyceridemia manifest more readily after resistance than endurance exercise. J Appl Physiol. 2008;105(4):1228–36.CrossRefPubMed
116.
Crouse SF, O’Brien BC, Rohack JJ, Lowe RC, Green JS, Tolson H, et al. Changes in serum lipids and apolipoproteins after exercise in men with high cholesterol: influence of intensity. J Appl Physiol. 1995;79(1):279–86.CrossRefPubMed
117.
Little JP, Langley J, Lee M, Myette-Côté E, Jackson G, Durrer C, et al. Sprint exercise snacks: a novel approach to increase aerobic fitness. Eur J Appl Physiol. 2019;119(5):1203–12.CrossRefPubMed
118.
Dempsey PC, Larsen RN, Sethi P, Sacre JW, Straznicky NE, Cohen ND, et al. Benefits for type 2 diabetes of interrupting prolonged sitting with brief bouts of light walking or simple resistance activities. Diabetes Care. 2016;39(6):964–72.CrossRefPubMed
119.
Tjønna AE, Rognmo Ø, Bye A, Stølen TO, Wisløff U. Time course of endothelial adaptation after acute and chronic exercise in patients with metabolic syndrome. J Strength Cond Res. 2011;25(9):2552–8.CrossRefPubMed
120.
Stanforth D, Brumitt J, Ratamess NA, Atkins W, Keteyian SJ. Training toys ... bells, ropes, and balls—oh my! ACSMs Health Fit J. 2015;19(4):5–11.CrossRef
Metadata
Title
The effects of high-intensity functional training on cardiometabolic risk factors and exercise enjoyment in men and women with metabolic syndrome: study protocol for a randomized, 12-week, dose-response trial
Authors
L. E. Smith
G. P. Van Guilder
L. C. Dalleck
N. K. Harris
Publication date
01-12-2022
Publisher
BioMed Central
Keywords
Insulins
Insulins
Published in
Trials / Issue 1/2022
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-022-06100-7

Other articles of this Issue 1/2022

Trials 1/2022 Go to the issue

Study protocol

Fostering shared decision-making about prostate cancer screening among African American men patients and their primary care providers: a randomized behavioral clinical trial

Study protocol

Comparison of weight loss induced by daily caloric restriction versus intermittent fasting (DRIFT) in individuals with obesity: study protocol for a 52-week randomized clinical trial

Study protocol

DICE: Dual mTorc Inhibition in advanCed/recurrent Epithelial ovarian cancer resistant to standard treatment—a study protocol for a randomised trial investigating a novel therapy called TAK228

Study protocol

Effectiveness of a mobile app-based educational intervention to treat internet gaming disorder among Iranian adolescents: study protocol for a randomized controlled trial

Update

ACL Surgery Necessity in Non-Acute Patients (ACL SNNAP): a statistical analysis plan for a randomised controlled trial

Study protocol

A randomised controlled trial to compare clinical and cost-effectiveness of an online parent-led treatment for child anxiety problems with usual care in the context of COVID-19 delivered in Child and Adolescent Mental Health Services in the UK (Co-CAT): a study protocol for a randomised controlled trial